TP53 and central nervous system cancer: Strategies to increase the virus oncolytic potential focus on enhancing apoptosis, as the recombinant rVV-p53 has shown a greater ability to trigger apoptosis in both in vitro glioma cells and animal tumor models compared with wt VV [69].